Roche Diagnostics recognizes Sentara Consolidated Laboratories as Roche Molecular Center of Excellence

PR Newswire — April 19, 2017

INDIANAPOLIS, April 19, 2017 /PRNewswire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY)
announced today the establishment of a strategic alliance with Sentara
Consolidated Laboratories of Norfolk, Va., that designates the institution as a
Roche Molecular Center of Excellence (MCOE).

Established in 2002, Roche’s MCOE network enables non-competing regional
laboratories across the U.S. to collaborate and capitalize on scientific
knowledge in molecular testing and, in turn, help accelerate the advancement of
new test methods and technology. Sentara Healthcare is an integrated healthcare
system that has 28,000 employees and includes 12 hospitals and multiple patient
care facilities across Virginia and North Carolina.

“Roche is very pleased to welcome Sentara Consolidated Laboratories into the
Molecular Centers of Excellence network,” said Jack Phillips, president and CEO
of Roche Diagnostics Corporation. “The network will especially benefit from
their expertise in lab quality, automation and informatics, and we look forward
to working together to implement molecular technologies for the advancement of
personalized medicine.”

Sentara is one of 33 labs that have received the MCOE designation and joined in
the strategic partnership. “This relationship with the MCOE network will help
keep Sentara on the forefront of diagnostics,” said Tabetha Sundin, Ph.D.,
acting director, Sentara Consolidated Laboratory Services. “It will also support
our focus on improving efficiency within the lab and ensuring that the right
test and right technology are used at the right time.”

As a nationally recognized Roche MCOE, Sentara Consolidated Laboratories will
offer physicians and patients some of the latest and most innovative
technologies in molecular and tissue diagnostics, and will help provide input to
Roche for the development of next-generation diagnostic solutions.

About Sentara Healthcare
Sentara Healthcare, based in Norfolk, Va., celebrates more than 125 years in
pursuit of its mission to improve health every day. Sentara is an integrated
not-for-profit system of 12 hospitals in Virginia and North Carolina, including
a Level I trauma center with Nightingale Regional Air Ambulance. The Sentara
family also includes four medical groups, ambulatory campuses, senior care
services, home care and hospice services, Medical Transport, LLC, the
physician-ledSentara Quality Care Network, the Sentara College of Health
Sciences, Optima Health Plan members in Virginia, Alabama and Ohio, and a team
of professionals 28,000 strong. Sentara is strategically focused on continuous
improvement in quality, safety, and the patient experience.

About the Roche Molecular Centers of Excellence (MCOE) network
Established in 2002, the Roche MCOE network includes about 30 leading U.S.
diagnostic laboratories and provides a forum to collaborate on strategies to
optimize the utilization of molecular solutions in laboratory testing. The
network leverages the expertise of thought leaders at these institutions to
advance current and emerging technologies–including molecular diagnostics,
tissue diagnostics and sequencing–to help laboratories address healthcare
challenges and contribute to improved patient care.

About Roche
Roche is a global pioneer in pharmaceuticals and diagnostics focused on
advancing science to improve people’s lives. The combined strengths of
pharmaceuticals and diagnostics under one roof have made Roche the leader in
personalized healthcare – a strategy that aims to fit the right treatment to
each patient in the best way possible.

Roche is the world’s largest biotech company, with truly differentiated
medicines in oncology, immunology, infectious diseases, ophthalmology and
diseases of the central nervous system. Roche is also the world leader in in
vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in
diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose
and treat diseases and make a sustainable contribution to society. The company
also aims for improving patient access to medical innovations by working with
all relevant stakeholders. Twenty-nine medicines developed by Roche are included
in the World Health Organization Model Lists of Essential Medicines, among them
life-saving antibiotics, antimalarials and cancer medicines. Roche has been
recognized as the Group Leader in sustainability within the Pharmaceuticals,
Biotechnology & Life Sciences Industry eight years in a row by the Dow Jones
Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100
countries and in 2016 employed more than 94,000 people worldwide. In 2016, Roche
invested CHF 9.9 billion in R&D and posted sales of CHF 50.6 billion. Genentech,
in the United States, is a wholly owned member of the Roche Group. Roche is the
majority shareholder in Chugai Pharmaceutical, Japan. For more information,
please visit www.roche.com or usdiagnostics.roche.com.

All trademarks mentioned in this release are protected by law.

For further information, please contact:

Roche
Mike Weist
Communications Business Partner, Molecular Diagnostics
Roche Diagnostics Corporation
Indianapolis, Indiana USA
(317) 521-3112
mike.weist@roche.com

Sentara Healthcare
Dale Gauding
Senior Communications Advisor
Sentara Healthcare
Norfolk, VA
(757) 455-7118
dtgaudin@sentara.com

To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/roche-diagnostics-recognizes-sentara-consolidated-laboratories-as-roche-molecular-center-of-excellence-300441251.html

SOURCE Roche Diagnostics

Subject Codes: PC/t.170419070007682, PT/lang.en, PC/ticker, IN/OTC,
IN/HEA, IN/PHA, IN/BIO, IN/MEQ, SU/OTC, RE/Indiana,
PC/priority.r, PC/category.f, PC/DataFeat_indpr,
PC/DataFeat_natl3, PC/port_32, PC/class.1245,
PC/WAVO_….h., PC/APT_….h, PC/trade_h, PC/wavo5_h,
PC/class.1030, PC/WAVO_l….., PC/APT_l…., PC/state_l,
PC/wavo1_l, PC/class.1000, PC/WAVO_..b…, PC/APT_..b..,
PC/circuit_b, PC/wavo3_b, PC/Billing_L58, PC/Billing_L72,
PC/Billing_L74, PC/Billing_RWB, PC/Billing_TNW,
PC/Billing_US1, PC/1stAcc_941334, PC/bureau_DE,
PC/port_01, PC/port_96, PC/port_31, PC/port_19,
PC/port_91, PC/website, PC/photo, PC/id_DE64871

Company Codes: OTC-BB:RHHBY, Swiss:RO, OTC-PINK:RHHBY, Swiss:ROG,
OTC-QX:RHHBY

Leave a Reply


Fatal error: Call to undefined function show_subscription_checkbox() in /home3/steer/public_html/indianapressreleases.com/wp-content/themes/comfy/comments.php on line 95